Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Case report and review of the literature: multiplanar CT as a supportive diagnostic tool in pleuroperitoneal leak during peritoneal dialysis.
Frontiers in medicine·2026
Same author
No Time to Bleed! Ultrasound-Guided Management of a Pleural Biopsy Complication: A Case Report.
Respirology case reports·2026
Same author
Skeletal muscle dysfunction in COPD: miRNAs, myokines and exercise.
ERJ open research·2026
Related Experiment Video
Updated: Apr 12, 2026
05:34
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
3.9K
INDACO project: COPD and link between comorbidities, lung function and inhalation therapy.
Giorgio Fumagalli1, Fabrizio Fabiani2, Silvia Forte2
1Pulmonary Departments, San Filippo Neri General Hospital, Rome, Italy ; UOC Pneumologia, A.C.O. San Filippo Neri, Via Martinotti, 20, 00135 Rome, Italy.
Multidisciplinary Respiratory Medicine
|May 15, 2015
Summary
Over 80% of Chronic Obstructive Pulmonary Disease (COPD) patients have comorbidities, which significantly influence treatment complexity. Gender differences in comorbidity prevalence were observed, impacting inhalation therapy decisions.
More Related Videos
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.7K
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.7K
Area of Science:
- Pulmonary Medicine
- Internal Medicine
- Epidemiology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) involves respiratory and systemic complications, including comorbidities that increase hospitalization and affect outcomes.
- These comorbidities can impact various organs and systems, complicating patient management.
- Current inhalation therapy for COPD primarily targets airflow obstruction, symptoms, and exacerbations.
Purpose of the Study:
- To evaluate the prevalence and types of comorbidities in COPD patients.
- To investigate the relationship between comorbidities and patient characteristics (sex, age, symptoms, lung function).
- To assess the impact of comorbidities on COPD inhalation therapy prescription.
Main Methods:
- Data from 569 COPD patients were analyzed, including anthropometric data, smoking history, respiratory function (GOLD stage), BMI, exacerbation history, and comorbidities.
- The Charlson Comorbidity Index (CCI) was used to quantify comorbidity burden.
- Relationships between comorbidities and clinical factors, as well as therapy complexity, were examined.
Main Results:
- A high prevalence of comorbidities (81.2%) was observed in COPD patients.
- Comorbidity number correlated with COPD exacerbations, dyspnea (MRC scale), and male gender, but not airflow obstruction or age.
- Ischemic heart disease was more common in males, while mood disorders were more prevalent in females.
- Complex inhalation therapy was associated with bronchial obstruction (FEV1/FVC) and the number of comorbidities.
- Multivariate analysis indicated airflow obstruction and comorbidity count as determinants of therapy complexity, though the model's explanatory power was low (r²=0.07).
Conclusions:
- COPD patients exhibit a high prevalence of comorbidities, with gender-specific patterns.
- The number of comorbidities and airflow obstruction are key factors influencing inhalation therapy prescription.
- Dyspnea and exacerbations, contrary to guidelines, were not significant drivers of therapy in this real-world setting.